Author name: Al Ingle

TL;DR: Google is updating its cryptocurrency ad policy to allow advertisements for blockchain-based games involving non-fungible tokens (NFTs). This move is seen as a major win for the NFT gaming community but has specific criteria to avoid encouraging gambling. Google’s Updated Crypto Ad Policy: Navigating the NFT Frontier As we edge closer to the last […]

T he recent sentencing of Enrique Tarrio, the leader of the Proud Boys, to 22 years in prison for his role related to the January 6 Capitol breach, has stirred a national debate around judicial consistency and proportionality. The case adds another layer of complexity, particularly in the context of unreleased footage from that day

T he marriage of economics and politics is as old as civilization itself, yet it remains a turbulent union at best. This turbulence manifests most clearly when societies face a choice between short-term relief and long-term stability. The 1920s British return to the gold standard is a compelling historical case that illustrates this tension. While

TL;DR: Elon Musk recently revealed that X (formerly known as Twitter) has experienced a 60% decline in U.S. revenue due to allegations of antisemitism. These claims have led multiple advertisers to pull out of the platform. In this analysis, we dive deep into the freedom of speech debate, scrutinize the role of the ADL, and

As the conversation around cryptocurrencies continues to evolve, few are as deeply committed to driving its adoption as Jose Garay, the CEO of Ibex. Founded in Guatemala, the company has been on the front lines of the Bitcoin revolution, specifically advancing the integration of the Lightning Network across Latin America. In a candid conversation with Bob Burnett

TL;DR: Today’s crypto landscape saw some dramatic developments. Circle’s USDC launches on Base and Optimism networks, MetaMask grapples with scammers using government websites, and Stake Casino reports a $41M hack. Coinbase reveals a new lending service, and Visa makes a strategic partnership. MetaMask introduces a game-changing ‘Sell’ feature, and Nvidia anticipates a $600B AI market

AI-Generated COVID Drug Marks a New Era In a significant breakthrough, Insilico Medicine’s AI-designed oral COVID-19 drug has entered Phase I clinical trials, signaling a seismic shift in how medications are researched and developed. The Hong Kong-based company claims the drug is effective against all variants of the virus, including those resistant to Pfizer’s Paxlovid. This